IMPACT BIOMEDICAL INC. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| DSS, INC. | — | Sale | 45,400 | $0.54 | $24,516 | — | May 22, 2025 |
| DSS, INC. | — | Sale | 890,800 | $0.95 | $846,260 | 161,100 | Apr 4, 2025 |
| Chan Heng Fai Ambrose | — | Sale | 351,555 | $0.50 | $175,778 | — | Apr 3, 2025 |
| Alset Inc. | — | Sale | 180,000 | $0.96 | $172,800 | — | Apr 2, 2025 |
| Alset International Ltd | — | Sale | 1,176,918 | $1.08 | $1,271,071 | 734,058 | Mar 31, 2025 |
| DSS, INC. | — | Sale | 166,600 | $3.30 | $549,780 | 1,178,882 | Mar 21, 2025 |
| DSS, INC. | — | Sale | 20 | $2.90 | $58 | 53,080 | Mar 20, 2025 |
| Heuszel Frank D | Chief Executive Officer | Purchase | 500 | $2.26 | $1,130 | 97,344 | Dec 5, 2024 |
| Heuszel Frank D | Chief Executive Officer | Purchase | 500 | $2.61 | $1,305 | 96,844 | Nov 27, 2024 |
| Heuszel Frank D | Chief Executive Officer | Purchase | 550 | $2.63 | $1,447 | 95,844 | Nov 26, 2024 |
| DSS, INC. | — | Sale | 500 | $2.76 | $1,380 | 58,300 | Nov 13, 2024 |
| DSS, INC. | — | Purchase | 1,000 | $2.33 | $2,330 | 58,800 | Sep 18, 2024 |
| DSS, INC. | — | Purchase | 50,000 | $2.69 | $134,500 | 50,000 | Sep 17, 2024 |